These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11328202)

  • 1. Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups.
    Koga M; Yuki N; Hirata K
    Acta Neurol Scand; 2001 May; 103(5):278-87. PubMed ID: 11328202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.
    Koga M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):513-6. PubMed ID: 10201426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.
    Ang CW; Yuki N; Jacobs BC; Koga M; Van Doorn PA; Schmitz PI; Van Der Meché FG
    Neurology; 1999 Dec; 53(9):2122-7. PubMed ID: 10599792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy.
    Yoshino H; Harukawa H; Asano A
    J Neuroimmunol; 2000 Jun; 105(2):195-201. PubMed ID: 10742563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection.
    Ogawara K; Kuwabara S; Koga M; Mori M; Yuki N; Hattori T
    J Neurol Sci; 2003 Jun; 210(1-2):41-5. PubMed ID: 12736086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
    Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
    Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
    Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
    J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-GQ1b IgG antibody syndrome: clinical and immunological range.
    Odaka M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):50-5. PubMed ID: 11118247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome.
    Koga M; Tatsumoto M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):123-4. PubMed ID: 11413278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands.
    Ang CW; Koga M; Jacobs BC; Yuki N; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2001 Dec; 121(1-2):83-7. PubMed ID: 11730944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bickerstaff's brainstem encephalitis associated with IgM antibodies to GM1b and GalNAc-GD1a.
    Matsuo M; Odaka M; Koga M; Tsuchiya K; Hamasaki Y; Yuki N
    J Neurol Sci; 2004 Feb; 217(2):225-8. PubMed ID: 14706228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
    J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.